Transcatheter Aortic Valve Implantation: Comparison of the Effects of Ultrasound-Guided Pericapsular Nerve Group Block and Fascia Iliaca Block on Postoperative Analgesia Management

Recruiting N/A Interventional Study
Aortic Valve Stenosis Transcatheter Aortic Valve Implantation Pericapsular Nerve Group Block Fascia Iliaca Block
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 85
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
60 (estimated)
Sponsor
Medipol University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Aortic Stenosis (AS) is the most common valvular pathology, particularly prevalent in advanced age, and Transcatheter Aortic Valve Implantation (TAVI) has become a crucial treatment option for high-risk patients who are not suitable for surgery. This minimally invasive approach has demonstrated successful clinical outcomes in patients deemed ineligible for surgical procedures. Patient selection c…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients scheduled for TAVİ * aged between 18 and 85 years, * American Society of Anesthesiology (ASA) physical status II-IV Exclusion Criteria: * History of bleeding diathesis. * Use of anticoagulant therapy. * History of chronic pain prior to surgery. * Multiple trauma. * …
Contacts

Burak Ömür

+905056215056

bomur@medipol.edu.tr

CONTACT